Eli Lilly (NYSE:LLY) Loses Migraine Drug Patent Trial to Teva
Teva Pharmaceuticals on Twitter: "Meet our #migraine expert, Dr Joshua Cohen, as he shares his own story of living with #migraine and explains the impact the disease can have on patients. Read
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
Fed Circ. upholds some Teva migraine drug patents, invalidates others | Reuters
FDA approves Teva's migraine injection AJOVY™ - Pf Media
Report: Teva Suffers Migraine Over Express Scripts Drug Exclusion - Pharmaceutical Processing World
Teva Canada Announces Product Availability of AJOVY™ | Business Wire
Ajovy Now Available in Autoinjector Device for Migraine Prevention - MPR
Teva - Migraine World Summit
Preventive Treatment of Migraine–AJOVY® (fremanezumab-vfrm) injection
Teva's recalled migraine medicine Zecuity has a long local history - Philadelphia Business Journal
Teva tries to make something out of nothing with Ajovy approval | Evaluate
Ajovy™ Approved by FDA for Migraine Prevention in Adults
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug – PharmaLive
With clock ticking on Teva migraine drug, analyst expresses doubt for approval | Fierce Pharma
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | Fierce Pharma
Teva stops selling migraine patch after reports of burns
Teva Halts Phase III Trial of Fremanezumab in Chronic Cluster Headaches
Teva Pharmaceutical Industries Ltd. - New research by Teva has thrown a spotlight on how badly affected women are by #migraine. But behind those numbers are real people. Come and meet some
Xconomy: Teva Migraine Drug Likely Delayed by Manufacturing Trouble
Teva scraps Heptares migraine pact as lead drug nears clinic | Fierce Biotech
Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement | Law.com
Teva notched a win in its migraine patent feud with Eli Lilly
